Glimepiride 2mgTablet
Diabetes & Metabolic

Glimepiride 2mg

Glimepiride

Third-generation sulfonylurea that stimulates pancreatic beta-cell insulin secretion via selective SUR1 receptor binding, offering a lower hypoglycemia risk compared to earlier sulfonylureas due to glucose-dependent activity. The most cost-effective oral antidiabetic agent in its class and a cornerstone of type 2 diabetes management in emerging markets.

Strengths

1mg / 2mg / 3mg / 4mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Glimepiride 1mg / 2mg / 3mg / 4mg
Dosage Form
Tablet
Available Strengths
1mg / 2mg / 3mg / 4mg
Packing
10 tablets/strip
Route of Administration
Oral, with breakfast or first main meal
Dosage
1-2mg once daily initially; increase by 1mg at 1-2 week intervals; usual maintenance 1-4mg; max 8mg/day
Indications
Type 2 diabetes mellitus (as monotherapy or in combination with metformin, insulin, or other antidiabetics)
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 25°C, protected from moisture and light
Shelf Life
36 months
Side Effects
Hypoglycemia, weight gain, nausea, diarrhea, dizziness, headache; rarely allergic skin reactions
Precautions
Risk of hypoglycemia (educate patient); dose reduction in renal impairment; avoid in type 1 diabetes and DKA; monitor blood glucose regularly; alcohol potentiates hypoglycemia

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Sitagliptin 100mgTablet

Sitagliptin 100mg

Sitagliptin Phosphate

First-in-class DPP-4 inhibitor that amplifies incretin-mediated glucose-dependent insulin secretion while suppressing glucagon, offering glycemic control without weight gain or intrinsic hypoglycemia risk. Once-daily dosing, renal dose adjustment flexibility, and a decade-long cardiovascular safety record make it a globally preferred add-on antidiabetic.

25mg / 50mg / 100mg
Vildagliptin 50mgTablet

Vildagliptin 50mg

Vildagliptin

Selective DPP-4 inhibitor with potent enzyme inhibition that improves glycemic control through enhanced incretin-mediated insulin secretion and suppressed post-meal glucagon release. Widely prescribed as a fixed-dose combination with metformin (Galvusmet) offering convenient dual-mechanism therapy without weight gain.

50mg
Pioglitazone 30mgTablet

Pioglitazone 30mg

Pioglitazone Hydrochloride

PPAR-gamma agonist thiazolidinedione that improves insulin sensitivity in peripheral tissues — muscle, fat, and liver — and favorably modifies lipid profiles by increasing HDL and reducing triglycerides. Uniquely addresses the underlying insulin resistance pathophysiology of type 2 diabetes and is widely used in combination regimens across Asia and Africa.

15mg / 30mg / 45mg

Need bulk pricing for Glimepiride 2mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote